Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy and immunomodulation in the elderly

F Fraschini1, G Gattei, G G Maierna

  • 1Department of Pharmacology, University of Milan, Italy.

Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Melatonin reduces the need for sedation in ICU patients: a randomized controlled trial.

Minerva anestesiologica·2015
Same author

Treatment of symptomatic lumbar spinal degenerative pathologies by means of combined conservative biochemical treatments.

Acta neurochirurgica. Supplement·2010
Same author

Pineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease.

European journal of histochemistry : EJH·2007
Same author

Penetration of amphotericin B in human lung tissue after single liposomal amphotericin B (AmBisome) infusion.

Journal of chemotherapy (Florence, Italy)·2005
Same author

Aging and vestibular system: specific tests and role of melatonin in cognitive involvement.

Archives of gerontology and geriatrics. Supplement·2004
Same author

Effect of multiple doses of clarithromycin and amoxicillin on IL-6, IFNgamma and IL-10 plasma levels in patients with community acquired pneumonia.

Journal of chemotherapy (Florence, Italy)·2004

Aging impairs bodily functions, necessitating consideration of patient senescence in treatments. This research focuses on developing neuroimmunomodulators to activate the weakened immune systems in elderly individuals.

Area of Science:

  • Gerontology and Immunology
  • Neuroscience and Oncology

Background:

  • Aging leads to a decline in overall bodily functions.
  • Elderly individuals often present with an immunodepressed state.
  • Current oncological treatments require adaptation for senescent patients.

Purpose of the Study:

  • To address the functional impairments associated with aging.
  • To explore therapeutic strategies for immunodepressed elderly populations.
  • To develop novel neuroimmunomodulators for immune system activation in the elderly.

Main Methods:

  • Review of current understanding of aging-related immune dysfunction.
  • Analysis of existing oncological and antimicrobial treatment protocols for the elderly.
  • Conceptualization of neuroimmunomodulatory approaches.

Related Experiment Videos

Main Results:

  • Identification of immune system impairment as a key factor in aging.
  • Recognition of the need for tailored treatments in elderly cancer patients.
  • Hypothesized potential of neuroimmunomodulators to restore immune function.

Conclusions:

  • Aging necessitates specialized medical approaches, particularly in oncology.
  • Targeting the immune system is crucial for treating elderly patients.
  • Neuroimmunomodulators hold promise for revitalizing the aging immune system.